• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICAL COMPANY INC. NRG TRANSSEPTAL NEEDLE; CATHETER, SEPTOSTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICAL COMPANY INC. NRG TRANSSEPTAL NEEDLE; CATHETER, SEPTOSTOMY Back to Search Results
Lot Number NGFD221221
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Low Blood Pressure/ Hypotension (1914); Pericardial Effusion (3271)
Date of Event 08/17/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The device won't be returned for analysis.Upon evaluation of the failure analysis of the event reported, if there is any further relevant information from that review, a supplemental medwatch will be filed.
 
Event or Problem Description
It was reported that a pericardial effusion occurred.A left atrial appendage (laa) closure procedure was attempted using a watchman truseal access system (was).Transseptal puncture (tsp) was performed with a nrg transseptal needle.Pericardial effusion (pe) was discovered shortly after the tsp and the was crossing the interatrial septum.The pe increased in size and the patient became hypotensive.After a pericardial drain was placed, blood was recirculated to the patient.The activated coagulation time (act) of the patient was 368 seconds at this point in the procedure.720ml of blood was drained and protamine was administered.Following administration of protamine an additional 180ml of blood was drained.After this additional blood was drained the act of the patient was 116 seconds.A further 10ml of blood was drained and the laa closure procedure was aborted.At an unspecified time following the procedure a pericardial window was placed.Six days post index procedure the patient fully recovered and was discharged.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NRG TRANSSEPTAL NEEDLE
Common Device Name
CATHETER, SEPTOSTOMY
Manufacturer (Section D)
BAYLIS MEDICAL COMPANY INC.
5959 trans-canada highway
montreal H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BAYLIS MEDICAL COMPANY INC.
5825 explorer drive
mississauga, on L4W 5 P6
CA   L4W 5P6
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key17646786
Report Number2124215-2023-46267
Device Sequence Number5970572
Product Code DXF
UDI-Device Identifier00685447000211
UDI-Public00685447000211
Combination Product (Y/N)N
Initial Reporter StateMO
Initial Reporter CountryUS
PMA/510(K) Number
K073326
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 08/29/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date01/05/2025
Device Lot NumberNGFD221221
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 08/17/2022
Initial Report FDA Received Date08/29/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured01/31/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient Age76 YR
Patient SexFemale
Patient RaceWhite
-
-